The crosstalk between Hippo/YAP and mTOR signaling pathways represents a metabolic vulnerability in cancers, highlighting opportunities for dual targeting of transcriptional and nutrient-sensing pathways to disrupt tumor progression. Here, YAP1 is linked to cancer.